These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 217063)

  • 1. [Current incidence and clinical significance of non-culturable bacilli or those culturable with difficulty].
    Golli V; Stefănescu I; Stefanin E; Zaharia P; Ionescu N
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(4):241-6. PubMed ID: 217063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and epidemiological significance of isolated cultures of Koch bacillus after conclusion of chemotherapy].
    Golli V; Ghiţulescu I; Ionescu N; Stefănescu F; Poneaş P
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):55-8. PubMed ID: 6264572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-culturable Koch bacilli during antitubercular chemotherapy].
    Moisescu V; Fanea E; Petrescu G; Popescu M; Rusu L; Ionescu D; Ariton G; Nicoară O; Molnar M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(2):91-8. PubMed ID: 195329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smear-negative pulmonary tuberculosis.
    Dutt AK; Stead WW
    Semin Respir Infect; 1994 Jun; 9(2):113-9. PubMed ID: 7973170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].
    Ito K; Aono A; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2005 Dec; 80(12):735-41. PubMed ID: 16447786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.
    Ramarokoto H; Randriamiharisoa H; Rakotoarisaonina A; Rasolovavalona T; Rasolofo V; Chanteau S; Ralamboson M; Cauchoix B; Rakotondramarina D
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):909-12. PubMed ID: 12365578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on tubercle bacilli and their contaminant bacteria in the sputum of pulmonary tuberculosis after chemotherapy ].
    Sakai I
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):211-6. PubMed ID: 6811390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K; Kawabata S; Masuda N
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the number and virulence of tubercle bacilli isolated form pulmonary tuberculosis during short course chemotherapy].
    Chen SH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):286-8, 318. PubMed ID: 2128212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A method of detecting tubercle bacilli in sputum].
    Takahashi Y
    Kekkaku; 1991 Feb; 66(2):81-5. PubMed ID: 1902535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Should the presence of Mycobacterium tuberculosis be demonstrated before the treatment of patients with suspected pulmonary tuberculosis?].
    Nørregaard J; Grode GW; Viskum K
    Ugeskr Laeger; 1994 Sep; 156(37):5276-8. PubMed ID: 7941064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
    Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of pathogens in the foci of pulmonary and osteo-articular tuberculosis].
    Klimenko MT; Ginzburg TS
    Probl Tuberk; 1990; (1):41-3. PubMed ID: 2110668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Middlebrook 7H9 broth for the rapid detection of mycobacteria.
    Flournoy D; Twilley J
    Clin Lab Sci; 2001; 14(2):85-8. PubMed ID: 15625980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.